comprehensive -WSS

comprehensive

author：knowledge 2025-09-28 21:04:58 - browse：6282

intarcia implant. -- health tech coverage from STAT — The matchstick-sized, implantable device from Intarcia Therapeutics releases a steady, continuous, and low-dose stream of a drug for diabetes. Stuart Isett/Fortune Brainstorm Health

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice.

Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision. FDA then granted Intarcia’s request. The agency is not bound to advisory panel decisions, though it tends to follow their advice.

Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The implant delivers a glucose-controlling medicine called exenatide, a member of the GLP-1 drugs that have taken the diabetes and obesity markets by storm. Intarcia’s implant continuously administers the drug over six months, with the goal of improving patient adherence compared to Eli Lilly and Novo Nordisk’s weekly GLP-1 shots.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Retired US general questions alleged Putin, Prigozhin meeting

WSS

340B reform proposal comes out of Senate working group

Updated Covid vaccine has 54% effectiveness, new study suggests

Top private equity targets in 2023: cardiology, clinical trials, lasers

Elizabeth Holmes on track for early release from her 11

Gene therapy for Afghan refugees’ infant will be fully covered

HCA discloses massive data breach affecting 11 million patients

focus

comprehensive

hotspot

What does generative AI mean for health care? We asked experts

N.Y. state detects polio case, first in the U.S. since 2013

United colonoscopy coverage change 'may cost lives,' doctors say

What’s missing from the debate over nursing home staff minimums

Jerome Adams on the need for new antivirals for Covid

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Wildfire smoke exposes gaps in outdoor worker protections

Surgery pushed Ben Carson to fame

Peter Hotez and the public health issue of online harassment

Why 40% Americans with Parkinson’s don’t see a neurologist

knowledge

Adopting new red light myopia treatments may be short

Living with Fabry disease, a condition that causes chronic pain

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

N.Y. state detects polio case, first in the U.S. since 2013

Study: Pain burden is higher in Black NFL players than white ones

N.Y. state detects polio case, first in the U.S. since 2013

hotspot

hotspot

entertainment

leisure time